Inaugural Allergan Horizon Grant recipients announced

November 13, 2006

Allergan announced the recipients of the first Allergan Horizon Grant Program. The company will contribute $1 million over 2 years to academic medical institutions to support fellows seeking to develop careers in academic medicine. The awards will fund fellowship programs that conduct clinical research in the diagnosis or pharmacological treatment of glaucoma, corneal, and retinal diseases.

Allergan announced the recipients of the first Allergan Horizon Grant Program. The company will contribute $1 million over 2 years to academic medical institutions to support fellows seeking to develop careers in academic medicine. The awards will fund fellowship programs that conduct clinical research in the diagnosis or pharmacological treatment of glaucoma, corneal, and retinal diseases.

Ten grants were awarded to 13 ophthalmology programs. Three programs will share the $40,000 between two therapeutic areas.

The recipients include:
Cornea

  • Anthony Aldave, MD, Jules Stein Eye Institute, University of California, Los Angeles


  • Roy S. Chuck, MD, Wilmer Eye Institute, Johns Hopkins University, Baltimore


  • Terry Kim, MD, Duke University Eye Center


  • Stephen Pflugfelder, MD, Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine

Glaucoma


  • Rand Allingham, MD, Duke University Medical Center


  • James D. Brandt, MD, University of California, Davis


  • Joseph Caprioli, MD, Jules Stein Eye Institute, University of California, Los Angeles


  • Robert Ritch, MD, New York Eye & Ear Infirmary


  • Robert Weinreb, MD, University of California, San Diego

Retina


  • Neil Bressler, MD, Wilmer Eye Institute


  • Stanley Chang, MD, Columbia University


  • Carmen Puliafito, MD, Bascom Palmer Eye Institute


  • Paul Sternberg Jr., MD, Vanderbilt Eye Institute

For more information, visit Allergan at Booth 2831.

Related Content:

News